Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Growth (Status and Outlook) 2022-2028
- LP 4889942
- 104 Pages
- March 2022
- Medical Devices
The United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market, reaching US$ million by the year 2028. As for the Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy players cover Pfizer, Novartis, Bristol Myers Squibb, and Legend Biotech, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Allogeneic CAR T-Cells
Autologous CAR T-Cells
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Diagnostic Center
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Pfizer
Novartis
Bristol Myers Squibb
Legend Biotech
Sorrento Therapeutics
CARSGEN Therapeutics，Ltd
Juno Therapeutics
Kite Pharma
Atara Biotherapeutics
Carina Biotech
Guangzhou Xiangxue Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2017-2028
2.1.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Segment by Type
2.2.1 Allogeneic CAR T-Cells
2.2.2 Autologous CAR T-Cells
2.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type
2.3.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)
2.4 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Segment by Application
2.4.1 Hospital
2.4.2 Diagnostic Center
2.4.3 Others
2.5 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application
2.5.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)
3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Player
3.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Players
3.1.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Players (2020-2022)
3.1.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Players (2020-2022)
3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Regions
4.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Regions (2017-2022)
4.2 Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth (2017-2022)
4.3 APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth (2017-2022)
4.4 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth (2017-2022)
4.5 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth (2017-2022)
5 Americas
5.1 Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2017-2022)
5.2 Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2017-2022)
5.3 Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2017-2022)
6.2 APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2017-2022)
6.3 APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Country (2017-2022)
7.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2017-2022)
7.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy by Region (2017-2022)
8.2 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2017-2022)
8.3 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Regions (2023-2028)
10.1.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Regions (2023-2028)
10.1.2 Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast
10.1.3 APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast
10.1.4 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast
10.1.5 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast
10.2 Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Country (2023-2028)
10.2.1 United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.2.2 Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.2.3 Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.2.4 Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.3 APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Region (2023-2028)
10.3.1 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.3.2 Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.3.3 Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.3.4 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.3.5 India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.3.6 Australia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.4 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Country (2023-2028)
10.4.1 Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.4.2 France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.4.3 UK Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.4.4 Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.4.5 Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.5 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Region (2023-2028)
10.5.1 Egypt Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.5.2 South Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.5.3 Israel Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.5.4 Turkey Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.5.5 GCC Countries Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Forecast
10.6 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Type (2023-2028)
10.7 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.1.3 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.2.3 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Information
11.3.2 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.3.3 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Bristol Myers Squibb Main Business Overview
11.3.5 Bristol Myers Squibb Latest Developments
11.4 Legend Biotech
11.4.1 Legend Biotech Company Information
11.4.2 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.4.3 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Legend Biotech Main Business Overview
11.4.5 Legend Biotech Latest Developments
11.5 Sorrento Therapeutics
11.5.1 Sorrento Therapeutics Company Information
11.5.2 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.5.3 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Sorrento Therapeutics Main Business Overview
11.5.5 Sorrento Therapeutics Latest Developments
11.6 CARSGEN Therapeutics，Ltd
11.6.1 CARSGEN Therapeutics，Ltd Company Information
11.6.2 CARSGEN Therapeutics，Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.6.3 CARSGEN Therapeutics，Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 CARSGEN Therapeutics，Ltd Main Business Overview
11.6.5 CARSGEN Therapeutics，Ltd Latest Developments
11.7 Juno Therapeutics
11.7.1 Juno Therapeutics Company Information
11.7.2 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.7.3 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Juno Therapeutics Main Business Overview
11.7.5 Juno Therapeutics Latest Developments
11.8 Kite Pharma
11.8.1 Kite Pharma Company Information
11.8.2 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.8.3 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Kite Pharma Main Business Overview
11.8.5 Kite Pharma Latest Developments
11.9 Atara Biotherapeutics
11.9.1 Atara Biotherapeutics Company Information
11.9.2 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.9.3 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Atara Biotherapeutics Main Business Overview
11.9.5 Atara Biotherapeutics Latest Developments
11.10 Carina Biotech
11.10.1 Carina Biotech Company Information
11.10.2 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.10.3 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Carina Biotech Main Business Overview
11.10.5 Carina Biotech Latest Developments
11.11 Guangzhou Xiangxue Pharmaceutical
11.11.1 Guangzhou Xiangxue Pharmaceutical Company Information
11.11.2 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
11.11.3 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Guangzhou Xiangxue Pharmaceutical Main Business Overview
11.11.5 Guangzhou Xiangxue Pharmaceutical Latest Developments
12 Research Findings and Conclusion
Table 1. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Allogeneic CAR T-Cells
Table 3. Major Players of Autologous CAR T-Cells
Table 4. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)
Table 7. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)
Table 10. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Player (2020-2022)
Table 12. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Key Players Head office and Products Offered
Table 13. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Regions (2017-2022)
Table 18. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Country (2017-2022)
Table 20. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)
Table 22. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)
Table 24. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Region (2017-2022)
Table 26. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)
Table 28. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)
Table 30. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Country (2017-2022)
Table 32. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)
Table 34. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
Table 43. Key Market Challenges & Risks of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
Table 44. Key Industry Trends of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
Table 45. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share Forecast by Application (2023-2028)
Table 51. Pfizer Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 52. Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 53. Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Pfizer Main Business
Table 55. Pfizer Latest Developments
Table 56. Novartis Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 57. Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Novartis Latest Developments
Table 61. Bristol Myers Squibb Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 62. Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 63. Bristol Myers Squibb Main Business
Table 64. Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Bristol Myers Squibb Latest Developments
Table 66. Legend Biotech Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 67. Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 68. Legend Biotech Main Business
Table 69. Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Legend Biotech Latest Developments
Table 71. Sorrento Therapeutics Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 72. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 73. Sorrento Therapeutics Main Business
Table 74. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Sorrento Therapeutics Latest Developments
Table 76. CARSGEN Therapeutics，Ltd Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 77. CARSGEN Therapeutics，Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 78. CARSGEN Therapeutics，Ltd Main Business
Table 79. CARSGEN Therapeutics，Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. CARSGEN Therapeutics，Ltd Latest Developments
Table 81. Juno Therapeutics Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 82. Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 83. Juno Therapeutics Main Business
Table 84. Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Juno Therapeutics Latest Developments
Table 86. Kite Pharma Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 87. Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 88. Kite Pharma Main Business
Table 89. Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Kite Pharma Latest Developments
Table 91. Atara Biotherapeutics Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 92. Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 93. Atara Biotherapeutics Main Business
Table 94. Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Atara Biotherapeutics Latest Developments
Table 96. Carina Biotech Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 97. Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 98. Carina Biotech Main Business
Table 99. Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Carina Biotech Latest Developments
Table 101. Guangzhou Xiangxue Pharmaceutical Details, Company Type, Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Area Served and Its Competitors
Table 102. Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offered
Table 103. Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Guangzhou Xiangxue Pharmaceutical Main Business
Table 105. Guangzhou Xiangxue Pharmaceutical Latest Developments
List of Figures
Figure 1. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type in 2021
Figure 7. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy in Hospital
Figure 8. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy in Diagnostic Center
Figure 10. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Diagnostic Center (2017-2022) & ($ Millions)
Figure 11. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy in Others
Figure 12. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application in 2021
Figure 14. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Player in 2021
Figure 15. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 17. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 18. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 20. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Value Market Share by Country in 2021
Figure 21. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Market Share by Type in 2021
Figure 22. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application in 2021
Figure 23. United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Region in 2021
Figure 28. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application in 2021
Figure 29. China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Country in 2021
Figure 36. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type in 2021
Figure 37. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application in 2021
Figure 38. Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Market Share by Application in 2021
Figure 46. Egypt Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 52. APAC Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 53. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 55. United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 56. Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 59. China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 60. Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 61. Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 63. India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 64. Australia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 65. Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 66. France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 67. UK Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 68. Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 69. Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 70. Spain Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 73. Israel Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
